India, Jan. 5 -- Panic gripped parents after multiple students fell ill at Jawahar Navodaya Vidyalaya (JNV) in Gurujang of Odisha's Khordha district. As per reports, samples of around 30 students te... Read More
India, Jan. 5 -- President Donald Trump has warned new Venezuelan leader Delcy Rodriguez ahead of her swearing in that she could "pay a very big price, probably bigger than Maduro" if she "doesn't do ... Read More
Afghanistan, Jan. 5 -- At least 30 people were killed when armed attackers stormed a busy market in northern Nigeria, torching stalls, looting food and abducting civilians, authorities said. At least... Read More
Dhaka, Jan. 5 -- Leaders of the left-leaning Left Democratic Alliance have held a meeting with BNP leader Tarique Rahman to discuss the country's current political situation, law and order, the econom... Read More
India, Jan. 5 -- Polyrizon Ltd. (PLRZ), Monday announced positive results from a new in-vitro pre-clinical study, evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation ... Read More
భారతదేశం, జనవరి 5 -- 2020 ఢిల్లీ అల్లర్ల వెనుక పెద్ద కుట్ర జరిపాడంటూ ఆరోపణలు ఎదుర్కొంటున్న జేఎన్యూ మాజీ విద్యార్థి ఉమర్ ఖలీద్కు సుప్రీంకోర్టులో మరోసారి నిరాశే ఎదురైంది. జనవరి 5న జరిగిన విచారణలో ఆయనక... Read More
భారతదేశం, జనవరి 5 -- మూడు దశాబ్దాల కెరీర్లో ఎప్పుడూ లేని విధంగా 2025 ఏడాది బాలీవుడ్ నటుడు అక్షయ్ ఖన్నాకు కలిసొచ్చింది. ఒకే ఏడాదిలో ఏకంగా రూ. 2000 కోట్ల గ్రాస్ వసూళ్లు సాధించిన రెండో భారతీయ నటుడిగా అత... Read More
New Delhi, Jan. 5 -- A lawsuit filed in Los Angeles County Superior Court has thrust Hollywood icon Will Smith into the center of a sexual harassment and wrongful termination scandal that threatens to... Read More
India, Jan. 5 -- Genelux Corporation (GNLX) on Monday reported interim results from two ongoing trials evaluating Olvi-Vec in patients with progressive lung cancer: a Phase 1b/2 study in small cell lu... Read More
India, Jan. 5 -- Zenas BioPharma (ZBIO) reported positive results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease. Obexelimab met the primary endpoint, demonstrating 5... Read More